In the Journals

This feature offers timely executive summaries of the most relevant journals in rheumatology. Through peer “Perspectives,” full bibliographical information and links to the original journal abstract, In the Journals are a step wider and deeper than journal reviews health care professionals may be accustomed.

In the Journals

Lower estrogen exposure linked to increased risk for Sjögren's syndrome in women

July 16, 2019
Primary Sjögren’s syndrome in women is associated with lower estrogen exposure and cumulative menstrual cycling, according to data published in…
In the Journals

EULAR stresses privacy, transparency in research using 'big data'

July 15, 2019
Rheumatic and musculoskeletal disorders researchers should consider the ethical issues surrounding privacy, confidentiality, identity and…
In the Journals

Lower stress predicts significant pain improvement in fibromyalgia

July 15, 2019
Reduced stress levels, and high pain intensity at baseline, predict an increased likelihood of significantly improved pain after 10 to 12 years among…
In the JournalsPerspective

Positive framing improves patients’ willingness to switch to biosimilar

July 11, 2019
Although patients express concerns regarding the safety and efficacy of biosimilars, physicians can improve willingness to switch to a biosimilar by…
In the Journals

Greater hip BMD gains seen with denosumab vs. teriparatide after long-term bisphosphonate use

July 11, 2019
Long-term bisphosphonate users who switched to the human monoclonal antibody denosumab experienced a gain in hip bone mineral density in the first…
In the Journals

American Indians exhibit high rates of Sjögren's syndrome, lack common disease features

July 11, 2019
American Indians are overrepresented among patients with Sjögren's syndrome, and demonstrate increased disease activity, despite presenting with few…
In the JournalsPerspective

Low disease activity, remission predict better quality of life in SLE

July 10, 2019
Low disease activity and remission are predictors of increased health-related quality of life in patients with systemic lupus erythematosus…
In the JournalsPerspective

Fasinumab improves pain, function in OA

July 10, 2019
Fasinumab, a recombinant, fully-human anti-nerve-growth-factor antibody, improved pain and physical function in patients with osteoarthritis, at…
In the Journals

Osteoarthritis more than doubles risk for multiple comorbidities

July 9, 2019
Individuals with osteoarthritis have a 2.5-times greater risk for having three or more other chronic conditions, including stroke and peptic ulcers…
In the Journals

Adalimumab yields superior outcomes vs. infliximab in Behçet’s-related uveitis

July 9, 2019
Adalimumab yielded better outcomes than infliximab in best-corrected visual acuity, retention and other areas among patients with uveitis related to…